JP2025518227A5 - - Google Patents
Info
- Publication number
- JP2025518227A5 JP2025518227A5 JP2024570699A JP2024570699A JP2025518227A5 JP 2025518227 A5 JP2025518227 A5 JP 2025518227A5 JP 2024570699 A JP2024570699 A JP 2024570699A JP 2024570699 A JP2024570699 A JP 2024570699A JP 2025518227 A5 JP2025518227 A5 JP 2025518227A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- weeks
- mazdutide
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210622648.7 | 2022-06-01 | ||
| CN202210622648 | 2022-06-01 | ||
| PCT/CN2023/093311 WO2023231730A2 (zh) | 2022-06-01 | 2023-05-10 | 使用mazdutide的治疗方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025518227A JP2025518227A (ja) | 2025-06-12 |
| JP2025518227A5 true JP2025518227A5 (cg-RX-API-DMAC7.html) | 2026-05-15 |
Family
ID=89026916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024570699A Pending JP2025518227A (ja) | 2022-06-01 | 2023-05-10 | mazdutideを使用する治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250296973A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4534095A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025518227A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250021331A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119584980A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023281591A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3257926A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023231730A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202617173A (zh) * | 2021-06-25 | 2026-05-01 | 大陸商信達生物製藥(蘇州)有限公司 | Mazdutide的應用 |
| EP4788362A1 (en) * | 2023-10-03 | 2026-08-12 | Innovent Biologics (Suzhou) Co., Ltd. | Methods of treating diabetes and obesity |
| WO2026002224A1 (en) * | 2024-06-27 | 2026-01-02 | Innovent Biologics (Suzhou) Co., Ltd. | Method of treating polycystic ovary syndrome |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI783244B (zh) * | 2015-06-22 | 2022-11-11 | 美商美國禮來大藥廠 | 升糖素及glp-1共激動劑化合物 |
| US11419918B2 (en) * | 2017-11-06 | 2022-08-23 | Shenzhen Turier Biotech Co., Ltd. | Treatment of biliary cirrhosis based on oxyntomodulin analogue GLP-1R/GCGR dual-target agonist peptide |
| CN111423506B (zh) * | 2019-11-08 | 2023-06-27 | 成都奥达生物科技有限公司 | 一种glp-1化合物 |
| TW202617173A (zh) * | 2021-06-25 | 2026-05-01 | 大陸商信達生物製藥(蘇州)有限公司 | Mazdutide的應用 |
-
2023
- 2023-05-10 AU AU2023281591A patent/AU2023281591A1/en active Pending
- 2023-05-10 CA CA3257926A patent/CA3257926A1/en active Pending
- 2023-05-10 KR KR1020247042558A patent/KR20250021331A/ko active Pending
- 2023-05-10 JP JP2024570699A patent/JP2025518227A/ja active Pending
- 2023-05-10 CN CN202380042982.8A patent/CN119584980A/zh active Pending
- 2023-05-10 EP EP23814915.7A patent/EP4534095A4/en active Pending
- 2023-05-10 US US18/869,519 patent/US20250296973A1/en active Pending
- 2023-05-10 WO PCT/CN2023/093311 patent/WO2023231730A2/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Krasagakis et al. | Management of severe scleroderma with long-term extracorporeal photopheresis | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2021193148A5 (cg-RX-API-DMAC7.html) | ||
| JP2009503020A5 (cg-RX-API-DMAC7.html) | ||
| JP2024527023A5 (cg-RX-API-DMAC7.html) | ||
| JP2023552700A5 (cg-RX-API-DMAC7.html) | ||
| CN1248170A (zh) | 含人体生长激素和皮质甾醇合成抑制剂的用于治疗代谢综合症的制剂 | |
| JP2025518227A (ja) | mazdutideを使用する治療方法 | |
| AU2009304002B9 (en) | A medicinal product and treatment | |
| CN107137417B (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| WO2024042518A1 (en) | Glp-1 receptor antagonist and methods of use thereof | |
| EP1274414A1 (en) | Nasal administration of agents for the treatment of gastroparesis | |
| JP2026016423A (ja) | Glp-1の投薬レジメン | |
| JP2022058873A5 (cg-RX-API-DMAC7.html) | ||
| JP2025060703A5 (cg-RX-API-DMAC7.html) | ||
| WO2024078507A1 (zh) | 麦角甾醇在制备防治胃溃疡药物中的应用 | |
| JP5034944B2 (ja) | インターフェロン作用物質の活性増強剤 | |
| JPS5998018A (ja) | 老化治療剤 | |
| JP2021169472A5 (cg-RX-API-DMAC7.html) | ||
| CN116019801B (zh) | 用于促进内源性生长激素分泌的氨基酸组合物 | |
| RU2024126016A (ru) | Лечение глиомы низкой степени злокачественности мирдаметинибом | |
| CN117243948A (zh) | 包含瑞香素的组合物在制备风湿性关节炎药物中的应用 | |
| CN121648265A (zh) | 司美格鲁肽与丁酸钠联用在制备用于减重的药物中的应用 | |
| JPH06234642A (ja) | 有機化合物に関する改良 | |
| JP2026500731A (ja) | 医薬組合せおよび医薬組成物、ならびにその使用方法 |